In previous studies, metformin has been shown to decrease the risk of cancer in type 2 diabetes. A recent meta-analysis showed a 34% reduction in the incidence of any cancer and a 33% reduction in cancer mortality; however, the studies are prone to bias and failed to confirm the results of observational studies.
-
-
Recent Posts
-
-